Clinical Trial Update: Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative Effects of Smokeless Tobacco Use [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completion of Phase 1/2 studies evaluating smokeless tobacco products with lower nicotine levels to reduce adverse effects as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Tobacco Use Disorder | Phase 1, Phase 2 | Status: COMPLETED